PPT-Chemotherapy of Tuberculosis

TUBERCULOSIS TUBERCULOSIS is an infectious disease caused by Mycobacteria Mycobacterium tuberculosis amp Mycobacterium bovis MODE OF TRANSMISSION Inhalation of droplets Ingestion self swallowing of infected sputum or ingestion of . When someone who is sick with TB coughs speaks laughs sings or sneezes people nearby may breathe TB bacteria into their lungs TB usually attacks the lungs but can also attack other parts of the body such as the brain spine or kidneys There are two t Government stewardship and accountability with monitoring and evaluation 2 Strong coalition with civil society organizations and communities 3 Protection and promotion of human rights ethics and equity 4 Adaptation of the strategy and targets at cou Program Goals. The Importance of Controlling Nausea and Vomiting in the Setting of Chemotherapy. CINV: Consequences. Emetogenicity of IV Chemotherapy. Emetogenicity of Oral Chemotherapy. Types of CINV. Chapter 16; Pages 797 to 815A. also Section 16.11: Drug Resistance. Folder Title: CxChemoPart1. Updated: . April 23, 2018. Therapeutic Modality Options. Surgery. Radiation: X-Ray; Photodynamic Therapy; Thermal Ablation; Microwave; . *. Morlan. Serrano Diana . Guadalupe Grupo: 1301. *. Santiago . Díaz . Ana . María. *Sánchez González . Sarai. ¿. Qué es?. Enfermedad infecciosa crónica, que llega a provocar zoonosis, causada por bacterias del genero . ries 14 61 contributed data on 17690 isolates whichThese drugs are more costly toxic and less effective thanfirst-line drugs used for routine treatment of TB with other diseases resistance to TB drugs . Dr. N.M. ABDUL KHADER JAILANI. Objectives. . To characterize the most common toxicities of conventional chemotherapy. To describe the relationship between the mechanism of action of a chemotherapy drug and its associated toxicities. Dr.. . Mohed. Shaker. A Brief History of Tuberculosis (TB). Tuberculosis (phthisis) described since the time of . Hippocrates (460 BC - 370 BC). . 1689: Doctor Richard Morton . used the term . “consumption”. Dr.. . Mohit. Bhatia. Assistant Professor. Department of Microbiology. AIIMS, . Rishikesh. LAYOUT. Introduction to Mycobacteria. Laboratory Diagnosis. General Features of Mycobacteria. Acid fastness . Cosivi O, Grange J, Daborn C, Raviglione M, Fujikura T, Cousins D, et al. Zoonotic Tuberculosis due to Mycobacterium bovis in Developing Countries. Emerg Infect Dis. 1998;4(1):59-70. https://doi.org/10.3201/eid0401.980108. Sola C, Devallois A, Horgen L, Maïsetti J, Filliol I, Legrand E, et al. Tuberculosis in the Caribbean: Using Spacer Oligonucleotide Typing to Understand Strain Origin and Transmission. Emerg Infect Dis. 1999;5(3):404-411. https://doi.org/10.3201/eid0503.990311. The treatment of drug-susceptible. and drug-resistant tuberculosis. Antwerp, 11 April 2019. Hans L Rieder. Efficacy, effectiveness, efficiency…. Efficacy. What can the drug do? (ideal conditions, simulated in clinical trial settings: factually evaluating . . The most common manifestation of CNS tuberculosis is leptomeningitis with enhancing basal exudates. Ventricular involvement is uncommon and occurs in late stages of disseminated. . TB. . meningitis.. General Features of Mycobacteria. Acid fastness . due to . Mycolic acids in the cell wall & Integrity of the cell wall. ™. Guanine plus cytosine (G+C) content of DNA of . Mycobacterium is 61–71 mol % (exception .